Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Apply
Gemcitabine, Cisplatin, Durvalumab & Pemigatinib
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step